ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Nephrology Self-Assessment Program (NephSAP)

nephSAP: Volume 17


130 6.1MB The quest to define the lower limits and perfusion requirements of the human kidney has never been more challenging.
NephSAP

Volume 17, Number 1, March 2018

Hypertension

Debbie L. Cohen, MD, Karen A. Griffin, MD
AMA PRA Category 1 Credits™

The quest to define the lower limits and perfusion requirements of the human kidney has never been more challenging....




101 3.3MB This issue of NephSAP is dedicated to interventional nephrology. This discipline was a nascent field in 2003 when all 18 ESRD Networks and the Centers for Medicare and Medicaid Services (CMS), together with clinicians, dialysis providers, and patients, de
NephSAP

Volume 17, Number 2, June 2018

Interventional Nephrology and Dialysis Access

Anil K. Agarwal MD, Lalathaksha Murthy Kumbar MD and Vandana Dua Niyyar MD
AMA PRA Category 1 Credits™

This issue of NephSAP is dedicated to interventional nephrology. This discipline was a nascent field in 2003 when all 18 ESRD Networks and the Centers for Medicare and Medicaid Services (CMS), together with clinicians, dialysis providers, and patients, de...




70 3.8MB Since the early 2000s, investigators have been studying the regulation and effects of elevated fibroblast growth factor 23 (FGF23) levels in the setting of CKD.
NephSAP

Volume 17, Number 3, August 2018

Disorders of Divalent Ions, Renal Bone Disease and Nephrolithiasis

Stanley Goldfarb, MD and Kevin J. Martin, MBBCh
AMA PRA Category 1 Credits™

Since the early 2000s, investigators have been studying the regulation and effects of elevated fibroblast growth factor 23 (FGF23) levels in the setting of CKD....




80 1.4MB Focal segmental glomerulosclerosis (FSGS) and collapsing glomerulopathy (CG) are distinct clinical pathologic syndromes that are associated with podocyte injury and podocyte precursor dysfunction, respectively.
NephSAP

Volume 17, Number 4, September 2018

Secondary Glomerular Diseases

Brad H. Rovin, MD
AMA PRA Category 1 Credits™

Focal segmental glomerulosclerosis (FSGS) and collapsing glomerulopathy (CG) are distinct clinical pathologic syndromes that are associated with podocyte injury and podocyte precursor dysfunction, respectively....